Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Gene therapy for erectile dysfunction.

Jesse N Mills1, Joseph E Dall'Era, Soren N Carlsen

  • 1University of Colorado at Denver Health Sciences Center, Division of Urology, Department of Surgery, Denver, CO, USA. Jesse.Mills@UCHSC.edu

Pharmacogenomics
|August 25, 2007
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Access without approval: state-level determinants of peptide availability in sexual medicine.

Sexual medicine·2026
Same author

The impact of tucking on fertility among transgender women: A systematic review.

International journal of transgender health·2026
Same author

Male hypogonadism: recommendations from the Fifth International Consultation on Sexual Medicine (ICSM 2024).

Sexual medicine reviews·2025
Same author

Ejaculatory function after robotic waterjet ablation for the treatment of benign prostatic hyperplasia: a systematic review.

International journal of impotence research·2025
Same author

Exploring the Clinical Landscape of Priapism Related to Intracavernosal Injection Therapy: Patient Characteristics, Management Patterns, and Erectile Dysfunction Outcomes.

Urology·2025
Same author

Risk factors, diagnosis, and long-term erectile dysfunction outcomes in priapism: a retrospective analysis of 186 cases from a single institution.

International journal of impotence research·2025
Same journal

Adherence to international pharmacogenomic recommendations in pediatric cancer care: a cohort analysis embedded within the MARVEL-PIC randomized trial.

Pharmacogenomics·2026
Same journal

Closely similar tacrolimus morning troughs and graft function across the recipients' common <i>ABCB1</i> polymorphisms (<i>c.2677G>T/A</i>, <i>c.1236C>T</i>, <i>c.3435C>T</i>) early after renal transplantation.

Pharmacogenomics·2026
Same journal

Pharmacogenomics for stratified antidepressant treatment in major depressive disorder: evidence, limits and a roadmap for clinical use.

Pharmacogenomics·2026
Same journal

Guidance from an informed public on collecting and sharing PGx test results for major depressive disorder: "It's no different from your blood type".

Pharmacogenomics·2026
Same journal

Optimizing pharmacogenomics workflows: a qualitative evaluation of clinical service delivery models.

Pharmacogenomics·2026
Same journal

Combinations of single gene predictors with AI-driven polygenic precision therapies in cardiovascular diseases.

Pharmacogenomics·2026
See all related articles

Gene therapy offers a promising new avenue for treating erectile dysfunction (ED) when oral medications fail. Research is advancing from animal studies to human trials, with significant developments expected soon.

Area of Science:

  • Urology
  • Molecular Biology
  • Regenerative Medicine

Background:

  • Erectile dysfunction (ED) affects approximately 50% of men over 50 in the US.
  • Oral phosphodiesterase inhibitors are effective for many, but not all, patients with ED.
  • Novel therapeutic strategies are needed for refractory ED cases.

Purpose of the Study:

  • To review the pathophysiology of erectile dysfunction.
  • To explore the molecular targets for novel gene therapies for ED.
  • To provide an overview of current gene therapy research in ED.

Main Methods:

  • Review of existing literature on ED pathophysiology.
  • Analysis of molecular pathways involved in erection.
  • Summary of preclinical (animal models) and clinical gene therapy studies for ED.

Related Experiment Videos

Main Results:

  • Detailed understanding of erection physiology has identified molecular targets for gene therapy.
  • Multiple research groups are investigating gene therapy in animal models of ED.
  • At least one gene therapy approach for ED has progressed to human clinical trials.

Conclusions:

  • Gene therapy represents a rapidly advancing field for ED treatment.
  • The translation of findings from animal models to human trials is ongoing.
  • This decade is anticipated to yield significant progress in gene therapy for ED.